Rosie Allen-Herring
Known title: DirectorCIK: 0001746329
Rosie Allen-Herring's purchase track record
Rosie Allen-Herring has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/17/2025 | WSBC | $20K | +13.7% | +7.2% | +0.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| WSBC | ▲ Buy | Grant | 2,417 | $0 | 4/23/2026 | View on chart |
| WSBC | ▲ Buy | Open Market | 800 | $20K | 9/17/2025 | View on chart |
| WSBC | ▲ Buy | Grant | 939 | $0 | 5/21/2025 | View on chart |
| WSBC | ▲ Buy | Grant | 1,749 | $0 | 4/17/2025 | View on chart |
| WSBC | ▲ Buy | Grant | 1,828 | $0 | 4/18/2024 | View on chart |
| WSBC | ▲ Buy | Grant | 803 | $0 | 5/24/2023 | View on chart |
| WSBC | ▲ Buy | Grant | 1,137 | $0 | 4/27/2023 | View on chart |
| WSBC | ▲ Buy | Grant | 155 | $0 | 5/18/2022 | View on chart |
| WSBC | ▲ Buy | Grant | 762 | $0 | 4/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
WesBanco Q3 Earnings Preview: Decline Expected
Analysts expect WesBanco's third-quarter earnings to decline, a key upcoming event for the stock. The company recently expanded its commercial footprint, and some analysis suggests the shares may be undervalued relative to their equity returns. The stock is currently trading near a significant support level, with an average analyst target price of $44.14.
WesBanco Q3 Earnings Preview: Decline Expected. Analysts expect WesBanco's third-quarter earnings to decline, a key upcoming event for the stock. The company recently expanded its commercial footprint, and some analysis suggests the shares may be undervalued relative to their equity returns. The stock is currently trading near a significant support level, with an average analyst target price of $44.14.